Skip to Content

Galenica Ltd. GALE

Morningstar Rating
CHF 71.50 +0.10 (0.14%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

GALE is trading at a 16% premium.
Price
CHF 71.52
Fair Value
CHF 47.86
Uncertainty
Medium
1-Star Price
CHF 99.37
5-Star Price
CHF 69.52
Economic Moat
Kdcxzg
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if GALE is a good fit for your portfolio.

Trading Information

Previous Close Price
CHF 71.40
Day Range
CHF 71.3071.70
52-Week Range
CHF 65.1078.15
Bid/Ask
CHF 71.45 / CHF 71.55
Market Cap
CHF 3.56 Bil
Volume/Avg
8,077 / 74,794

Key Statistics

Price/Earnings (Normalized)
21.71
Price/Sales
0.95
Dividend Yield (Trailing)
3.08%
Dividend Yield (Forward)
3.08%
Total Yield
3.25%

Company Profile

Galenica Ltd is an integrated healthcare service provider in Switzerland. The business is operated from two segments Products & Care and Logistics & IT. The Products & Care segment comprises the Retail business area with offerings for patients and end customers and the Professionals business area with offerings for business customers and partners in the healthcare sector. The Logistics & IT segment comprises the two sectors Wholesale and Logistics & IT Services. These provide services for all those involved in the healthcare sector - pharmacies, drugstores, doctors, hospitals and care homes, partners, and suppliers.
Sector
Healthcare
Industry
Medical Distribution
Stock Style Box
Mid Core
Total Number of Employees
5,907

Comparables

Valuation

Metric
GALE
DOCM
NBLY
Price/Earnings (Normalized)
21.7137.89
Price/Book Value
2.422.051.42
Price/Sales
0.950.900.95
Price/Cash Flow
14.0713.98
Price/Earnings
GALE
DOCM
NBLY

Financial Strength

Metric
GALE
DOCM
NBLY
Quick Ratio
0.881.270.40
Current Ratio
1.341.631.14
Interest Coverage
21.40−5.36−0.27
Quick Ratio
GALE
DOCM
NBLY

Profitability

Metric
GALE
DOCM
NBLY
Return on Assets (Normalized)
10.03%−12.29%−1.59%
Return on Equity (Normalized)
20.87%−28.68%−2.93%
Return on Invested Capital (Normalized)
18.15%−12.54%0.86%
Return on Assets
GALE
DOCM
NBLY
See how this stock stacks up to its competitors with Morningstar Investor

Medical Distribution Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MCK
McKesson CorpYcqxmclwCgcdzw$72.2 Bil
COR
Cencora IncJrjslpnDkvrhc$44.7 Bil
CAH
Cardinal Health IncDytqclwCnflkqc$23.9 Bil
SHPMF
Shanghai Pharmaceuticals Holding Co Ltd Class HJqvscr$8.3 Bil
SHPMY
Shanghai Pharmaceuticals Holding Co Ltd ADR repr Class HDxvgn$8.3 Bil
SHTDF
Sinopharm Group Co LtdMlqfs$8.3 Bil
SHTDY
Sinopharm Group Co Ltd ADRMwzkj$8.3 Bil
AMFPF
Amplifon SpA Az nom Post FrazionamentoKwyshz$8.1 Bil
MAHLY
Medipal Holdings Corp ADRLltj$3.3 Bil
MEPDF
Medipal Holdings CorpTwnp$3.3 Bil

Sponsor Center